Literature DB >> 24986696

A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.

Jun Sawada1, Ryosuke Orimoto2, Tatsuro Misu3, Takayuki Katayama4, Hitoshi Aizawa5, Asuka Asanome4, Kae Takahashi4, Tsukasa Saito4, Ryogo Anei2, Kyousuke Kamada2, Naoyuki Miyokawa2, Toshiyuki Takahashi3, Kazuo Fujihara3, Naoyuki Hasebe4.   

Abstract

A woman with Sjögren syndrome manifesting as aphasia with a left deep cerebral white matter lesion tested positive for anti-aquaporin 4 (AQP4) antibody. Open biopsy of the lesion revealed active demyelination with edematous changes and the preservation of most axons, indicating a non-necrotic demyelinating lesion. Immunostaining for AQP4 was diffusely lost, whereas the loss of glial fibrillary acidic protein immunostaining was limited but with highly degenerated astrocytic foot processes in perivascular areas. These results suggested neuromyelitis optica spectrum disorder (NMOSD) pathology rather than Sjögren-related vasculitis. Only cerebral cortical symptoms with a cerebral white matter lesion could be observed in NMOSDs.
© The Author(s), 2014.

Entities:  

Keywords:  Neuromyelitis optica spectrum disorder (NMOSD); Sjögren syndrome (SS); anti-aquaporin (AQP4) antibody; magnetic resonance imaging (MRI); pathology; white matter lesion

Mesh:

Substances:

Year:  2014        PMID: 24986696     DOI: 10.1177/1352458514540834

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  2 in total

1.  A Case of Primary Sjögren's Syndrome Presenting as Mass-Like Encephalitis, With Progression to Neuromyelitis Optica Spectrum Disorder.

Authors:  Hyun-Jung Lee; Sung Hae Chang; Eun Ha Kang; Yun Jong Lee; Yeong Wook Song; You-Jung Ha
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

2.  Neuromyelitis optica spectrum disorder complicated with Sjögren's syndrome: first pediatric case responsive to mycophenolate mofetil treatment.

Authors:  Gao-Li Fang; Wei Fang; Yang Zheng; Yin-Xi Zhang
Journal:  Acta Neurol Belg       Date:  2020-11-02       Impact factor: 2.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.